| 图片： | |
|---|---|
| 名称： | |
| 描述： | |
- B311813岁乳腺肿物
图1
图2
图3
图4
图5
图6
图7
图8
图9
图10
图11
图12
| 姓 名： | ××× | 性别： | 女 | 年龄： | 13 |
| 标本名称： | |||||
| 简要病史： | |||||
| 肉眼检查： | 包膜完整 | ||||
免疫组化：2张CD10、2张CK5、1张p63
病变主要为后两张图中左侧区域表现，制片6张，其中有2张切片中出现微乳头结构
标签：幼年性纤维腺瘤 ADH
- The More We See, The Less We Know!
相关帖子
- • 乳腺导管内癌乳头状亚型
- • 乳腺肿物
- • 导管原位癌or不典型增生
- • 女性 冰冻为乳腺浸润性导管癌，现切除标本，肿块旁组织
- • 女性 33岁 乳腺肿块
- • 乳腺包块
- • 乳腺两个相邻导管内的病变
- • 乳腺肿物
- • 乳腺包块。33岁
- • 左乳肿块，协助诊断
×参考诊断
-
本帖最后由 于 2011-02-06 18:57:00 编辑
| 以下是引用cqzhao在2011-2-5 21:13:00的发言：
If it is a breast core biopsy, we need to consider the wording. It will decide if excisional biopsy is needed. For this case the 13 y girl had excisional bx already. It makes no difference for the clinical mangment (follow up only) if we report 幼年性纤维腺瘤 or 幼年性纤维腺瘤with ADH. We should know them meaning of ADH. ADH means the women can have increased ca risk compared with no ADH women. Pathologists make diagnosis based on the known criteria. If you have a good study with many similar cases with long term follow up and the patients have no increase ca risk, you can say these morphological features in young patients are benign, which should not be called ADH |
谢谢赵老师
本单位按照“纤维腺瘤伴轻中度不典型增生”向临床报告，并注明无需进一步处理，随访即可
- The More We See, The Less We Know!
